Organisation paid for research Program year 2024 Source: CMS Open Payments

Atlanta Behavioral Rsrch

Neither a doctor nor a teaching hospital

Research payments

$4,843

26 payments

Through program year 2024, Atlanta Behavioral Rsrch is reported as receiving $4,843 in research payments, across 26 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2024	Research	$3,671	2
2023	Research	$799	13
2022	Research	$373	11

Breakdown

Who paid Research payments · program years 2022–2024

Sumitomo Pharma America, Inc. $4,470 15 payments
Sunovion Pharmaceuticals Inc. $373 11 payments

Studies the money was for Research payments · program years 2022–2024

A Multi-region, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating SEP-4199 Controlled Release (CR) for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression) $3,671 2 payments
A 24-Week Open-Label Study Evaluating the Effectiveness Safety and Tolerability of SEP-363856 in Subjects with Schizophrenia Switched from Typical or Atypical Antipsychotic Agents OLE. $799 13 payments
A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder. $373 11 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.